A New Look at Blood Transfusion: Evaluation of the risks and benefits prompts careful blood management. Joint Commission Perspectives on Patient Safety, January 2007, Volume 7, Issue 1.
Krebs VE, Higuera C, Barsoum WK, Helfand R. Blood Management in Joint Replacement Surgery: What’s in and What’s Out. Orthopedics 2006; 29:801.
Blanchette CM, Wang PF, Joshi AV, Asmussen M, Saunders W, Kruse P. Cost and utilization of blood transfusion associated with spinal surgeries in the United States. Eur Spine J. 2006; 1-11. DOI 10.1007/s00586-006-0066-3.
Spence RK. Current concepts and issues in blood management. Orthopedics, 2004; 27(6 Suppl), S643-51.
Polk HC jr, Miles AA. Enhancement of bacterial infection by ferric iron with the degredation of red blood cells, potentially leading to infection; kinetics, mechanisms and surgical significance. Surgery 70:71-77, 1971.
Candrilli S, Mauskopf J. How much does a hospital day cost? 11th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Philadelphia, PA; 2006.
Steinitz D, Harvey EJ, Leighton RK, Petrie DP. Is homologous blood transfusion a risk factor for infection after hip replacement? Can J Surg. 2001; 44:355-8.
Blanchette CM, Wang PF, Joshi AV, Kruse P, Asmussen M, Saunders W. Resource utilization and costs of blood management services associated with knee and hip surgeries in US Hospitals. Adv Ther. 2006; 23:54-67.
Innerhofer P, Klingler A, Klimmer C, Fries D, Nussbaumer W. Risk for postoperative infection after transfusion of white blood cell-filtered allogeneic or autologous blood components in orthopedic patients undergoing primary arthroplasty. Transfusion 2005 45:103-110.
J.L Carson, D.G Altman, A Duff, H Noveck, M.P Weinstein, F.A Sonnenberg, J.I Hudson, G Provenzano. Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion. 1999; 39:694-700.
Siegel HJ, Sparks DR, Casillas MA, Hong H, Dunham WH. The use of bipolar hemosealing technology in orthopedic oncology: safety and clinical impact. Orthopedics 2008; 31:10.
Keating EM, Ritter MA. Transfusion options in total joint arthroplasty. J Arthroplasty. 2002;17 (Suppl. 1), 125-7.
Patney MJ. Economic Considerations When Using Transcollation technology to Reduce Blood Transfusions in Total Joint Replacement. Data on file.
Weeden SH, Schmidt RH, Isabell G. Haemostatic efficacy of a bipolar sealing device in minimally invasive total knee arthroplasty (Abstract). 8th Congress Of The European Federation Of National Associations Of Orthopaedics And Traumatology, 2007. Florence, Italy.
Snyder BD, Hedequist DJ, Shannon EG. Hemostatic efficacy of bipolar wound sealer as adjunct to wound management in children with neuromuscular scoliosis (abstract). Annual Meeting of the Pediatric Orthopaedic Society of North America, 2007.
Mont MA, Krebs VJ, Bierbaum BE, Goldberg VS, Ries MD. Hemostasis in primary unilateral knee arthroplasty using a bipolar sealer. Data on file.
Rosenberg AG. Reducing blood loss in total joint surgery with a saline-coupled bipolar sealing technology. J Arthroplasty. 2007; 22(4 Suppl 1):82-5.
Marulanda GA, Ragland PS, Seyler TM, Mont MA. Reduction in blood loss with use of a bipolar sealer for hemostasis in primary total knee arthroplasty. Surg Technol Int. 2005;14:281-6.
Mont MA, Marulanda GA, Ulrich SD, Seyler TM, Delanois RE. Reductions in blood loss with a bipolar sealer in total hip arthroplasty. Expert Rev Med Devices. 2008; 5:125-131.
Rosen MJ. Transcollation technology for primary total joint replacement: Clinical and economic benefits. Data on file.